Meyer MC - Search Results

1

Carbamazepine level-A in vivo-in vitro correlation (IVIVC): a scaled convolution based predictive approach.

Veng-Pedersen P, Gobburu JV, Meyer MC, Straughn AB. Veng-Pedersen P, et al. Among authors: meyer mc. Biopharm Drug Dispos. 2000 Jan;21(1):1-6. doi: 10.1002/1099-081x(200001)21:1<1::aid-bdd207>3.0.co;2-d. Biopharm Drug Dispos. 2000. PMID: 11038432 Clinical Trial.

2

In vitro and in vivo evaluation of seven 50 mg and 100 mg nitrofurantoin tablets.

Meyer MC, Wood GC, Straughn AB. Meyer MC, et al. Biopharm Drug Dispos. 1989 May-Jun;10(3):321-9. doi: 10.1002/bdd.2510100310. Biopharm Drug Dispos. 1989. PMID: 2720135 Clinical Trial.

3

The bioinequivalence of carbamazepine tablets with a history of clinical failures.

Meyer MC, Straughn AB, Jarvi EJ, Wood GC, Pelsor FR, Shah VP. Meyer MC, et al. Pharm Res. 1992 Dec;9(12):1612-6. doi: 10.1023/a:1015872626887. Pharm Res. 1992. PMID: 1488405

4

The absorption of sustained-release methylphenidate formulations compared to an immediate-release formulation.

Patrick KS, Straughn AB, Jarvi EJ, Breese GR, Meyer MC. Patrick KS, et al. Among authors: meyer mc. Biopharm Drug Dispos. 1989 Mar-Apr;10(2):165-71. doi: 10.1002/bdd.2510100206. Biopharm Drug Dispos. 1989. PMID: 2706316 Clinical Trial.

5

Bioavailability of seven furosemide tablets in man.

Straughn AB, Wood GC, Raghow G, Meyer MC. Straughn AB, et al. Among authors: meyer mc. Biopharm Drug Dispos. 1986 Mar-Apr;7(2):113-20. doi: 10.1002/bdd.2510070203. Biopharm Drug Dispos. 1986. PMID: 3708119 Clinical Trial.

6

Plasma levels of ethaverine after oral administration to humans.

Meyer MC, Raghow G, Straughn AB. Meyer MC, et al. Biopharm Drug Dispos. 1983 Oct-Dec;4(4):401-4. doi: 10.1002/bdd.2510040412. Biopharm Drug Dispos. 1983. PMID: 6661518

7

Relative bioavailability of acetazolamide tablets.

Straughn AB, Gollamudi R, Meyer MC. Straughn AB, et al. Among authors: meyer mc. Biopharm Drug Dispos. 1982 Jan-Mar;3(1):75-82. doi: 10.1002/bdd.2510030110. Biopharm Drug Dispos. 1982. PMID: 7082781 Clinical Trial.

8

Biopharmaceutical factors in seizure control and drug toxicity.

Meyer MC, Straughn AB. Meyer MC, et al. Am J Hosp Pharm. 1993 Dec;50(12 Suppl 5):S17-22. Am J Hosp Pharm. 1993. PMID: 8122697 Review.

9

Lack of in vivo/in vitro correlations for 50 mg and 250 mg primidone tablets.

Meyer MC, Straughn AB, Mhatre RM, Shah VP, Williams RL, Lesko LJ. Meyer MC, et al. Pharm Res. 1998 Jul;15(7):1085-9. doi: 10.1023/a:1011942530288. Pharm Res. 1998. PMID: 9688064 Clinical Trial.

10

The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tablets.

Meyer MC, Straughn AB, Mhatre RM, Shah VP, Williams RL, Lesko LJ. Meyer MC, et al. Pharm Res. 1998 Nov;15(11):1787-91. doi: 10.1023/a:1011929300613. Pharm Res. 1998. PMID: 9834004 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page